Product image of Micropaque Ct (Barium Sulfate) supplied by GNH India

Micropaque Ct

Active Ingredient:
Barium Sulfate
Origin:
EU

Micropaque Ct (Barium Sulfate)

Barium sulfate, the active ingredient in Micropaque Ct, is a contrast media presented as a powder for oral suspension for oral use. It provides radiopaque contrast for imaging of the gastrointestinal tract in patients undergoing diagnostic procedures.

GNH India supplies Micropaque Ct as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Guerbet

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Micropaque Ct is a radiographic contrast agent used for gastrointestinal imaging procedures.

  • Barium swallow: enhances visualization of the esophagus during swallowing studies.
  • Barium meal: provides contrast for assessment of stomach and duodenal anatomy.
  • CT imaging of gastrointestinal tract: improves delineation of bowel loops in computed tomography examinations.

How It Works

  • Barium sulfate contains a high atomic number element that strongly attenuates X‑ray photons. When the powder is mixed into a suspension and ingested, it coats the mucosal surface of the gastrointestinal lumen, creating a radiopaque lining that appears white on X‑ray, fluoroscopy, or CT images, thereby highlighting the shape and integrity of the GI tract for diagnostic evaluation.

Side Effects

Adverse reactions may occur following oral administration of Micropaque Ct.

Common Side Effects

  • Nausea: mild to moderate feeling of queasiness.
  • Abdominal discomfort: cramping or fullness in the stomach.
  • Constipation: reduced bowel movements after the study.
  • Diarrhoea: loose stools in some patients.
  • Mild vomiting: occasional emesis shortly after ingestion.
  • Metallic taste: transient metallic sensation in the mouth.

Serious or Rare Side Effects

  • Allergic reaction: rash, itching, or anaphylaxis requiring immediate medical attention.
  • Aspiration pneumonia: risk if the suspension is inhaled instead of swallowed.
  • Severe constipation leading to bowel obstruction.
  • Gastrointestinal perforation: especially in patients with existing ulcers or strictures.
  • Electrolyte imbalance: rare disturbances due to fluid shifts.
  • Severe hypersensitivity: bronchospasm or angioedema.

Precautions & Warnings

Prior to using Micropaque Ct, clinicians should consider several safety measures.

  • Assess for known GI obstruction: avoid use in patients with suspected or confirmed bowel blockage.
  • Screen for hypersensitivity: discontinue immediately if an allergic reaction develops.
  • Consider recent bowel surgery: use with caution in postoperative patients.
  • Avoid in patients with severe constipation or ileus: risk of worsening obstruction.
  • Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Micropaque Ct may interact with other agents that affect imaging quality or gastrointestinal function.

Major Interactions (Avoid)

  • Concurrent use of oral iodinated contrast agents: may increase overall radiodensity and compromise image interpretation.
  • Antacids containing aluminum or magnesium: can bind barium and reduce contrast efficacy.

Moderate Interactions (Monitor Closely)

  • Proton pump inhibitors: may alter gastric pH, affecting barium coating.
  • Laxatives: may change transit time and impact image quality.
  • Diuretics: potential electrolyte shifts if severe dehydration occurs.

Frequently Asked Questions

Micropaque Ct is an oral barium sulfate suspension used as a radiographic contrast medium to enhance X‑ray, fluoroscopic, and CT images of the gastrointestinal tract during procedures such as barium swallow, barium meal, and CT enterography.

Barium sulfate contains a high‑density element that absorbs X‑ray photons. When ingested, it coats the lining of the GI tract, creating a radiopaque layer that appears white on imaging, allowing clinicians to visualize the shape, size, and any abnormalities of the esophagus, stomach, and intestines.

The dose of Micropaque Ct is determined by the prescribing physician based on the specific imaging study, patient age, weight, and clinical indication. The product is supplied as a powder that is reconstituted into a suspension according to the label instructions before administration.

The safety of Micropaque Ct in pregnancy or lactation has not been definitively established. It should only be used if the diagnostic benefit outweighs potential risks, and the decision should be made by the treating physician in consultation with the patient.

To order Micropaque Ct, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Micropaque Ct (barium sulfate) provides higher radiodensity than water‑soluble iodinated agents, resulting in clearer images of the GI lumen. However, unlike iodinated agents, it is not suitable for patients with suspected perforation or severe constipation, where a water‑soluble contrast may be preferred.

Micropaque Ct should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture and direct sunlight. Once reconstituted, the suspension should be used within the time frame indicated on the label and any unused portion discarded.

The powder is mixed with a specified volume of water to create a uniform suspension. The patient drinks the suspension under medical supervision, typically after fasting, to ensure optimal coating of the gastrointestinal tract for imaging.

Serious risks include allergic reactions such as anaphylaxis, aspiration pneumonia if the suspension is inhaled, severe constipation leading to bowel obstruction, and gastrointestinal perforation in patients with existing ulcers or strictures. Immediate medical attention is required if any of these occur.

Micropaque Ct should be avoided in patients with known or suspected bowel obstruction, severe constipation, recent gastrointestinal surgery, perforated GI tract, or a documented hypersensitivity to barium sulfate. The prescribing clinician must evaluate each patient’s suitability before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.